CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation

CDK inhibitors: positive and negative regulators of G1-phase progression

Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · see citing works

An Integrated Genomic Analysis of Human Glioblastoma Multiforme

Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · see citing works

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · see citing works

The landscape of somatic copy-number alteration across human cancers

Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017 · see citing works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969 · see citing works

Cell cycle, CDKs and cancer: a changing paradigm

Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · see citing works

p21 is a universal inhibitor of cyclin kinases

Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691 · see citing works

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works

A cell cycle regulator potentially involved in genesis of many tumor types

Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · see citing works

Whole genomes redefine the mutational landscape of pancreatic cancer

Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642 · see citing works

The regulation of E2F by pRB-family proteins.

Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · see citing works

CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors

Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,248 · see citing works

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,208 · see citing works

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

Polyák, K., Lee, M.-H., Erdjument‐Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118 · see citing works

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works

pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950 · see citing works

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Preprint

Polyak, K., Kato, J., Solomon, M., Sherr, C., Massagué, J., Roberts, J., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,949 · see citing works

Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair

Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908 · see citing works

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742 · see citing works

NF‐κB and the link between inflammation and cancer

DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,490 · see citing works

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

Lim, S., & Kaldis, P. (2013) · Development · doi:10.1242/dev.091744 · Cited by 1,483 · see citing works

To cycle or not to cycle: a critical decision in cancer

Malumbres, M., & Barbacid, M. (2001) · Nature reviews. Cancer · doi:10.1038/35106065 · Cited by 1,475 · see citing works

New functional activities for the p21 family of CDK inhibitors.

LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402 · see citing works

Inflammation meets cancer, with NF-κB as the matchmaker

Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,378 · see citing works

Mammalian cyclin-dependent kinases

Malumbres, M., & Barbacid, M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.09.005 · Cited by 1,294 · see citing works

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264 · see citing works

Retinoblastoma protein recruits histone deacetylase to repress transcription

Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,231 · see citing works

A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma

Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann, E., Plaen, E. D., Hankeln, T., Büschenfelde, K. M. Z., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,153 · see citing works

The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts

Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · see citing works

Living with or without cyclins and cyclin-dependent kinases

Sherr, C. J., & Roberts, J. M. (2004) · Genes & Development · doi:10.1101/gad.1256504 · Cited by 1,089 · see citing works

Functional Inactivation of the Retinoblastoma Protein Requires Sequential Modification by at Least Two Distinct Cyclin-cdk Complexes

Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,077 · see citing works

D-Type Cyclin-Dependent Kinase Activity in Mammalian Cells

Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,067 · see citing works

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · see citing works

Inhibition of cyclin-dependent kinases by p21.

Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B. D., Tsai, L., Zhang, P., Dobrowolski, S. F., Bai, C., Connell‐Crowley, L., & Swindell, E. C. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,025 · see citing works

D-type cyclins

Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980 · see citing works

Minireview: Cyclin D1: Normal and Abnormal Functions

Fu, M., Wang, C., Li, Z., Sakamaki, T., & Pestell, R. G. (2004) · Endocrinology · doi:10.1210/en.2004-0959 · Cited by 961 · see citing works

Rb Interacts with Histone Deacetylase to Repress Transcription

Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 957 · see citing works

A family of human cdc2‐related protein kinases.

Meyerson, M. M., Enders, G. H., Wu, C. L., Su, L., Gorka, C., Nelson, C. E., Harlow, E., & Tsai, L. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05360.x · Cited by 925 · see citing works

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Schmitz, R., Young, R. M., Ceribelli, M., Jhavar, S. G., Xiao, W., Zhang, M., Wright, G. W., Shaffer, A. L., Hodson, D. J., Buras, E. D., et al. (2012) · Nature · doi:10.1038/nature11378 · Cited by 920 · see citing works

The p16INK4a/CDKN2A tumor suppressor and its relatives

Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911 · see citing works

Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex

Russo, A. A., Jeffrey, P. D., Patten, A. K., Massagué, J., & Pavletich, N. P. (1996) · Nature · doi:10.1038/382325a0 · Cited by 907 · see citing works

Cell cycle kinases as therapeutic targets for cancer

Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 906 · see citing works

Rb targets histone H3 methylation and HP1 to promoters

Nielsen, S. J., Schneider, R., Bauer, U., Bannister, A. J., Morrison, A. J., O’Carroll, D., Firestein, R., Cleary, M. L., Jenuwein, T., Herrera, R. E., et al. (2001) · Nature · doi:10.1038/35087620 · Cited by 901 · see citing works

Identification and properties of an atypical catalytic subunit (p34PSK-J3/Cdk4) for mammalian D type G1 cyclins

Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897 · see citing works

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.Preprint

Lee, M., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889 · see citing works

The diverse and complex roles of NF-κB subunits in cancer

Perkins, N. D. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3204 · Cited by 845 · see citing works

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · see citing works

Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Meyerson, M. M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 799 · see citing works

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Malumbres, M., Sotillo, R., Santamarı́a, D., Galán, J., Cerezo, A., Ortega, S., Dubus, P., & Barbacid, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.002 · Cited by 793 · see citing works

Physical interaction of the retinoblastoma protein with human D cyclins

Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 746 · see citing works

Signatures of mutation and selection in the cancer genome

Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707 · see citing works

Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia

Rane, S. G., Dubus, P., Mettus, R. V., Galbreath, E. J., Boden, G., Reddy, E. P., & Barbacid, M. (1999) · Nature Genetics · doi:10.1038/8751 · Cited by 700 · see citing works

Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and RB-hSWI/SNF.

Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., & Dean, D. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80625-x · Cited by 658 · see citing works

Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle

Ekholm, S. V., & Reed, S. I. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00151-4 · Cited by 587 · see citing works

p16 ^INK4A is a robust <i>in vivo</i> biomarker of cellular aging in human skin

Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter‐Kochanek, K., Jansen‐Dürr, P., & Wlaschek, M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00231.x · Cited by 557 · see citing works

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

Anders, L., Ke, N., Hydbring, P., Choi, Y. J., Widlund, H. R., Chick, J. M., Zhai, H., Vidal, M., Gygi, S. P., Braun, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.001 · Cited by 543 · see citing works

Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation.Preprint

Xiong, Y., Zhang, H., & Beach, D. (1993) · Genes & Development · doi:10.1101/gad.7.8.1572 · Cited by 507 · see citing works

Cyclin-dependent kinases regulate the antiproliferative function of Smads

Matsuura, I., Denissova, N. G., Wang, G., He, D., Long, J., & Liu, F. (2004) · Nature · doi:10.1038/nature02650 · Cited by 506 · see citing works

Cyclin-dependent kinases: a family portrait

Malumbres, M., Harlow, E. E., Hunt, T., Hunter, T. R., Lahti, J. M., Manning, G., Morgan, D. O., Tsai, L., & Wolgemuth, D. J. (2009) · Nature Cell Biology · doi:10.1038/ncb1109-1275 · Cited by 499 · see citing works

Assembly of cyclin D-dependent kinase and titration of p27 ^Kip1 regulated by mitogen-activated protein kinase kinase (MEK1)

Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496 · see citing works

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics

Jares, P., Colomer, D., & Campo, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2230 · Cited by 466 · see citing works

Moonlighting proteins: An intriguing mode of multitasking

Huberts, D. H. E. W., & van der Klei, I. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.022 · Cited by 456 · see citing works

Function of a human cyclin gene as an oncogene.

Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., & Weinberg, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.709 · Cited by 451 · see citing works

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

Schmidt, E., Ichimura, K., Reifenberger, G., & Collins, V. P. (1994) · PubMed · Cited by 436 · see citing works

Requirement for CDK4 kinase function in breast cancer

Yu, Q., Sicinska, E., Geng, Y., Ahnström, M., Zagozdzon, A., Kong, Y., Gardner, H., Kiyokawa, H., Harris, L. N., Stål, O., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.012 · Cited by 429 · see citing works

A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma

Puyol, M., Martín, A., Dubus, P., Mulero, F., Pizcueta, P., Khan, G., Guerra, C., Santamaría, D., & Barbacid, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.025 · Cited by 415 · see citing works

A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer

Lamb, J., Ramaswamy, S., Ford, H. L., Contreras, B., Martinez, R. V. P., Kittrell, F. S., Zahnow, C. A., Patterson, N. J., Golub, T. R., & Ewen, M. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00570-1 · Cited by 410 · see citing works

Endogenous Purification Reveals GREB1 as a Key Estrogen Receptor Regulatory Factor

Mohammed, H., D’Santos, C., Serandour, A. A., Ali, H. R., Brown, G. D., Atkins, A., Rueda, O. M., Holmes, K. A., Theodorou, V., Robinson, J. L. L., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.010 · Cited by 400 · see citing works

Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27 ^Kip1 Activity

Tsutsui, T., Hesabi, B., Moons, D. S., Pandolfi, P. P., Hansel, K. S., Koff, A., & Kiyokawa, H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7011 · Cited by 395 · see citing works

Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure

Dean, J. L., Thangavel, C., McClendon, A. K., Reed, C. A., & Knudsen, E. S. (2010) · Oncogene · doi:10.1038/onc.2010.154 · Cited by 393 · see citing works

Cyclin D1 Stimulation of Estrogen Receptor Transcriptional Activity Independent of cdk4†

Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., DiRenzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M. A., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5338 · Cited by 393 · see citing works

Tailoring to RB: tumour suppressor status and therapeutic response

Knudsen, E. S., & Knudsen, K. E. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2401 · Cited by 345 · see citing works

The Requirement for Cyclin D Function in Tumor Maintenance

Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., Signoretti, S., Look, A. T., Kung, A. L., von Boehmer, H., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.015 · Cited by 342 · see citing works

CDK6 Levels Regulate Quiescence Exit in Human Hematopoietic Stem Cells

Laurenti, E., Frelin, C., Xie, S. Z.-J., Ferrari, R., Dunant, C. F., Zandi, S., Neumann, A. L., Plumb, I., Doulatov, S. R., Chen, J., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.017 · Cited by 340 · see citing works

A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers

Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333 · see citing works

Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis

Landis, M. W., Pawlyk, B. S., Li, T., Sicinski, P., & Hinds, P. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.019 · Cited by 329 · see citing works

The Transcription Factor EGR1 Controls Both the Proliferation and Localization of Hematopoietic Stem Cells

Min, I. M., Pietramaggiori, G., Kim, F. S., Passegue, E. A., Stevenson, K. E., & Wagers, A. J. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.01.015 · Cited by 327 · see citing works

Pharmacologic Inhibition of Cyclin-Dependent Kinases 4 and 6 Arrests the Growth of Glioblastoma Multiforme Intracranial Xenografts

Michaud, K., Solomon, D. A., Oermann, E. K., Kim, J.-S., Zhong, W.-Z., Prados, M. D., Ozawa, T., James, C. D., & Waldman, T. A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4559 · Cited by 321 · see citing works

FOXM1, a typical proliferation-associated transcription factor

Wierstra, I., & Alves, J. (2007) · Biological Chemistry · doi:10.1515/bc.2007.159 · Cited by 313 · see citing works

A Kinase-Independent Function of CDK6 Links the Cell Cycle to Tumor Angiogenesis

Kollmann, K., Heller, G., Schneckenleithner, C., Warsch, W., Scheicher, R., Ott, R. G., Schäfer, M., Fajmann, S., Schlederer, M., Schiefer, A.-I., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.012 · Cited by 313 · see citing works

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer

Konecny, G. E., Winterhoff, B. J. N., Kolarova, T. R., Qi, J., Manivong, K., Dering, J., Yang, G., Chalukya, M., Wang, H.-J., Anderson, L. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2307 · Cited by 303 · see citing works

The meaning of p16^ink4aexpression in tumors: Functional significance, clinical associations and future developments

Witkiewicz, A. K., Knudsen, K. E., Dicker, A. P., & Knudsen, E. S. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16776 · Cited by 286 · see citing works

Signaling through cyclin D-dependent kinases

Choi, Y., & Anders, L. (2013) · Oncogene · doi:10.1038/onc.2013.137 · Cited by 279 · see citing works

Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4

Blain, S. W., Montalvo, E., & Massagué, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25863 · Cited by 279 · see citing works

Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen

Bienvenu, F., Jirawatnotai, S., Elias, J. E., Meyer, C. A., Mizeracka, K., Marson, A., Frampton, G. M., Cole, M. F., Odom, D. T., Odajima, J., et al. (2010) · Nature · doi:10.1038/nature08684 · Cited by 276 · see citing works

Cyclin D1 Inhibits Peroxisome Proliferator-activated Receptor γ-mediated Adipogenesis through Histone Deacetylase Recruitment

Fu, M., Rao, M., Bouras, T., Wang, C., Wu, K., Zhang, X., Li, Z., Yao, T., & Pestell, R. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500403200 · Cited by 274 · see citing works

CDK6 as a key regulator of hematopoietic and leukemic stem cell activation

Scheicher, R., Hoelbl‐Kovacic, A., Bellutti, F., Tigan, A.-S., Prchal‐Murphy, M., Heller, G., Schneckenleithner, C., Salazar‐Roa, M., Zöchbauer‐Müller, S., Zuber, J. A., et al. (2014) · Blood · doi:10.1182/blood-2014-06-584417 · Cited by 263 · see citing works

CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1.

Bates, S., Bonetta, L. P., MacAllan, D., Parry, D., Holder, A. A., Dickson, C., & Peters, G. (1994) · PubMed · Cited by 260 · see citing works

Structure of the Rb C-Terminal Domain Bound to E2F1-DP1: A Mechanism for Phosphorylation-Induced E2F Release

Rubin, S. M., Gall, A.-L., Zheng, N., & Pavletich, N. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.044 · Cited by 253 · see citing works

Nuclear Cyclin D1/CDK4 Kinase Regulates CUL4 Expression and Triggers Neoplastic Growth via Activation of the PRMT5 Methyltransferase

Aggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H. S., Gurung, B., Nakagawa, H., Herlyn, M., Hua, X., Rustgi, A. K., McMahon, S. B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.012 · Cited by 243 · see citing works

Structural basis of inhibition of CDK–cyclin complexes by INK4 inhibitorsPreprint

Jeffrey, P. D., Tong, L., & Pavletich, N. P. (2000) · Genes & Development · doi:10.1101/gad.851100 · Cited by 239 · see citing works

Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer.

Sulli, G., Di Micco, R., & di Fagagna, F. D. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3344 · Cited by 238 · see citing works

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

Sánchez-Martínez, C., Gelbert, L. M., Lallena, M. J., & de Dios, A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.05.100 · Cited by 236 · see citing works

Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression

Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., et al. (2014) · Nature · doi:10.1038/nature13267 · Cited by 234 · see citing works

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

Wiedemeyer, W. R., Dunn, I. F., Quayle, S. N., Zhang, J., Chheda, M. G., Dunn, G. P., Zhuang, L., Rosenbluh, J., Chen, S., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001613107 · Cited by 223 · see citing works

Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.

Tam, S. W., Shay, J. W., & Pagano, M. (1994) · PubMed · Cited by 222 · see citing works

Transcriptional Repression by the Retinoblastoma Protein through the Recruitment of a Histone Methyltransferase

Vandel, L., Nicolas, E., Vaute, O., Ferreira, R., Ait‐Si‐Ali, S., & Trouche, D. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.19.6484-6494.2001 · Cited by 214 · see citing works

New Roles of Cyclin D1

Pestell, R. G. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.03.001 · Cited by 197 · see citing works

Cyclin D1 Repression of Peroxisome Proliferator-Activated Receptor γ Expression and Transactivation

Wang, C., Pattabiraman, N., Zhou, J., Fu, M., Sakamaki, T., Albanese, C., Li, Z., Wu, K., Hulit, J., Neumeister, P., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.17.6159-6173.2003 · Cited by 195 · see citing works

D-type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability.

Knudsen, K. E., Cavenee, W. K., & Arden, K. C. (1999) · PubMed · Cited by 185 · see citing works

Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia

Sawai, C. M., Freund, J., Oh, P., Ndiaye-Lobry, D., Bretz, J. C., Strikoudis, A., Genesca, L., Trimarchi, T., Kelliher, M. A., Clark, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.016 · Cited by 183 · see citing works

The Transcription Factor FOXM1 (Forkhead box M1)

Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 174 · see citing works

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

Parry, D., Mahony, D., Wills, K., & Lees, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1775 · Cited by 174 · see citing works

Requirement for CDK6 in MLL-rearranged acute myeloid leukemia

Placke, T., Faber, K., Nonami, A., Putwain, S. L., Salih, H. R., Heidel, F. H., Krämer, A., Root, D. E., Barbie, D. A., Krivtsov, A. V., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558114 · Cited by 170 · see citing works

Gene Expression and Cell Cycle Arrest Mediated by Transcription Factor DMP1 Is Antagonized by D-Type Cyclins through a Cyclin-Dependent-Kinase-Independent Mechanism

Inoue, K., & Sherr, C. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1590 · Cited by 168 · see citing works

Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition

Dean, J. L., McClendon, A. K., & Knudsen, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365494 · Cited by 156 · see citing works

Phosphorylation-induced Conformational Changes in the Retinoblastoma Protein Inhibit E2F Transactivation Domain Binding

Burke, J. R., Deshong, A. J., Pelton, J. G., & Rubin, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108167 · Cited by 148 · see citing works

Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.

van der Velden, P. A., Metzelaar-Blok, J. A. W., Bergman, W., Monique, H., Hurks, H. M. H., Frants, R. R., Gruis, N. A., & Jager, M. J. (2001) · PubMed · Cited by 147 · see citing works

Gene expression patterns define novel roles for E47 in cell cycle progression, cytokine-mediated signaling, and T lineage development

Schwartz, R., Engel, I., Fallahi‐Sichani, M., Petrie, H. T., & Murre, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603728103 · Cited by 144 · see citing works

Induction of <i>ARF</i> tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1

Inoue, K., Roussel, M. F., & Sherr, C. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3993 · Cited by 144 · see citing works

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescencePreprint

Zou, X., Ray, D., Aziyu, A., Christov, K. T., Boiko, A. D., Gudkov, A. V., & Kiyokawa, H. (2002) · Genes & Development · doi:10.1101/gad.1033002 · Cited by 143 · see citing works

PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers

Li, Y., Chitnis, N., Nakagawa, H., Kita, Y., Natsugoe, S., Yang, Y., Li, Z., Wasik, M., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0625 · Cited by 143 · see citing works

Cyclin-Dependent Kinase 6 Is a Chromatin-Bound Cofactor for NF-κB-Dependent Gene Expression

Handschick, K., Beuerlein, K., Jurida, L., Bartkuhn, M., Müller, H., Soelch, J., Weber, A., Dittrich-Breiholz, O., Schneider, H., Scharfe, M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.002 · Cited by 141 · see citing works

Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1

Benzeno, S., Lu, F., Guo, M., Barbash, O., Zhang, F., Herman, J. G., Klein, P. S., Rustgi, A. K., & Diehl, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209644 · Cited by 141 · see citing works

Bone Morphogenetic Protein 2-Induced Osteoblast Differentiation Requires Smad-Mediated Down-Regulation of Cdk6

Ogasawara, T., Kawaguchi, H., Jinno, S., Hoshi, K., Itaka, K., Takato, T., Nakamura, K., & Okayama, H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6560-6568.2004 · Cited by 140 · see citing works

Cell-Cycle Control of Developmentally Regulated Transcription Factors Accounts for Heterogeneity in Human Pluripotent Cells

Singh, A. M., Chappell, J., Trost, R., Lin, L., Wang, T., Tang, J., Wu, H., Zhao, S., Jin, P., & Dalton, S. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.10.009 · Cited by 136 · see citing works

Cell Cycle Control and HIV-1 Susceptibility Are Linked by CDK6-Dependent CDK2 Phosphorylation of SAMHD1 in Myeloid and Lymphoid Cells

Pauls, E., Ruiz, A., Badía, R., Permanyer, M., Gubern, A., Riveira‐Muñoz, E., Torres‐Torronteras, J., Álvarez, M., Mothe, B., Brander, C., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400873 · Cited by 127 · see citing works

Cell-Cycle Control of Developmentally Regulated Transcription Factors Accounts for Heterogeneity in Human Pluripotent Cells

Singh, A. M., Chappell, J., Trost, R., Lin, L., Wang, T., Tang, J., Matlock, B. K., Weller, K. P., Wu, H., Zhao, S., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.02.009 · Cited by 126 · see citing works

CDK6 associates with the centrosome during mitosis and is mutated in a large Pakistani family with primary microcephaly

Hussain, M. S., Baig, S. M., Neumann, S., Peche, V. S., Szczepanski, S., Nürnberg, G., Tariq, M., Jameel, M., Khan, T. N., Fatima, A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt374 · Cited by 126 · see citing works

Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response

Li, Z., Jiao, X., Wang, C., Shirley, L. A., Elsaleh, H., Dahl, O., Wang, M., Soutoglou, E., Knudsen, E. S., & Pestell, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0312 · Cited by 124 · see citing works

Targeting cell cycle regulators in hematologic malignancies

Aleem, E. A., & Arceci, R. J. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00016 · Cited by 122 · see citing works

Cyclin D1-Cdk4 Induce Runx2 Ubiquitination and Degradation

Shen, R., Wang, X., Drissi, H., Liu, F., O’Keefe, R. J., & Chen, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603439200 · Cited by 117 · see citing works

A Requirement for Cyclin-Dependent Kinase 6 in Thymocyte Development and Tumorigenesis

Hu, M. G., Deshpande, A., Enos, M., Mao, D., Hinds, E. A., Hu, G., Chang, R., Guo, Z., Dose, M., Mao, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2473 · Cited by 116 · see citing works

ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice

Casimiro, M. C., Crosariol, M., Loro, E., Ertel, A., Yu, Z., Dampier, W., Saria, E. A., Papanikolaou, A., Stanek, T. J., Li, Z., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60256 · Cited by 115 · see citing works

Cdk6 blocks myeloid differentiation by interfering with Runx1 DNA binding and Runx1‐C/EBPα interaction

Fujimoto, T., Anderson, K., Jacobsen, S. E. W., Nishikawa, S.-I., & Nerlov, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601675 · Cited by 110 · see citing works

Cyclin-Dependent Kinase 4 Expression Is Essential for Neu-Induced Breast Tumorigenesis

Reddy, H. K. D. L., Mettus, R. V., Rane, S. G., Graña, X., Litvin, J., & Reddy, E. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2639 · Cited by 105 · see citing works

Proteomic Identification of a Direct Role for Cyclin D1 in DNA Damage Repair

Jirawatnotai, S., Hu, Y., Livingston, D. M., & Siciński, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3549 · Cited by 105 · see citing works

Aberrations of p16Ink4 and retinoblastoma tumour‐suppressor genes occur in distinct sub‐sets of human cancer cell lines

Aagaard, L., Lukas, J., Bártková, J., Kjerulff, A. A., Strauss, M., & Bártek, J. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610120 · Cited by 102 · see citing works

Cyclin D–cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiationPreprint

Lazaro, J., Bailey, P. J., & Lassar, A. B. (2002) · Genes & Development · doi:10.1101/gad.u-9988r · Cited by 100 · see citing works

Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsPreprint

Hua, J., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., et al. (2011) · Genes & Development · doi:10.1101/gad.17620611 · Cited by 99 · see citing works

Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia.

Chilosi, M., Doglioni, C., Yan, Z., Lestani, M., Menestrina, F., Sorio, C., Benedetti, A., Vinante, F., Pizzolo, G., & Inghirami, G. (1998) · Europe PMC (PubMed Central) · Cited by 96 · see citing works

Cyclin-Dependent Kinase 6 Phosphorylates NF-κB P65 at Serine 536 and Contributes to the Regulation of Inflammatory Gene Expression

Buss, H., Handschick, K., Jurrmann, N., Pekkonen, P., Beuerlein, K., Müller, H., Wait, R., Saklatvala, J., Ojala, P. M., Schmitz, M. L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051847 · Cited by 92 · see citing works

Cyclin D1 Represses p300 Transactivation through a Cyclin-dependent Kinase-independent Mechanism

Fu, M., Wang, C., Rao, M., Wu, X., Bouras, T., Zhang, X., Li, Z., Jiao, X., Yang, J., Li, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503188200 · Cited by 91 · see citing works

Regulation of transcription and chromatin structure by pRB: Here, there and everywhere

Talluri, S., & Dick, F. A. (2012) · Cell Cycle · doi:10.4161/cc.21263 · Cited by 88 · see citing works

CDK6 kinase activity is required for thymocyte development

Hu, M. G., Deshpande, A., Schlichting, N., Hinds, E. A., Mao, C., Dose, M., Hu, G., Etten, R. A. V., Gounari, F., & Hinds, P. W. (2011) · Blood · doi:10.1182/blood-2010-08-300517 · Cited by 84 · see citing works

The ARF tumour suppressor

Gallagher, S. J., Kefford, R. F., & Rizos, H. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.02.008 · Cited by 81 · see citing works

Multiple Functions of D-Type Cyclins Can Antagonize pRb-Mediated Suppression of Proliferation

Baker, G. L., Landis, M. W., & Hinds, P. W. (2004) · Cell Cycle · doi:10.4161/cc.4.2.1485 · Cited by 79 · see citing works

Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma

Nagel, S., Leich, E., Quentmeier, H., Meyer, C., Kaufmann, M., Drexler, H. G., Zettl, A., Rosenwald, A., & MacLeod, R. (2007) · Leukemia · doi:10.1038/sj.leu.2405028 · Cited by 77 · see citing works

CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells

Matushansky, I., Radparvar, F., & Skoultchi, A. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206484 · Cited by 77 · see citing works

Activation of cyclin D1-kinase in murine fibroblasts lacking both p21Cip1 and p27Kip1

Sugimoto, M., Martin, N., Wilks, D. P., Tamai, K., Huot, T. J. G., Pantoja, C., Okumura, K., Serrano, M., & Hara, E. (2002) · Oncogene · doi:10.1038/sj.onc.1206019 · Cited by 77 · see citing works

Negative Regulation of TSC1-TSC2 by Mammalian D-Type Cyclins

Zacharek, S. J., Xiong, Y., & Shumway, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2236 · Cited by 72 · see citing works

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

Zhang, L., Fried, F. B., Guo, H. W., & Friedman, A. D. (2007) · Blood · doi:10.1182/blood-2007-08-109702 · Cited by 68 · see citing works

Dmp1 and tumor suppression

Inoue, K., Mallakin, A., & Frazier, D. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210226 · Cited by 67 · see citing works

Osteoclast Differentiation by RANKL Requires NF-κB-Mediated Downregulation of Cyclin-Dependent Kinase 6 (Cdk6)

Ogasawara, T., Katagiri, M., Yamamoto, A., Hoshi, K., Takato, T., Nakamura, K., Tanaka, S., Okayama, H., & Kawaguchi, H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2004.19.7.1128 · Cited by 62 · see citing works

The Stat3 paradox: A killer and an oncogene

Resemann, H. K., Watson, C. J., & Lloyd‐Lewis, B. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.029 · Cited by 58 · see citing works

In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene

Hayette, S., Tigaud, I., Callet‐Bauchu, E., Ffrench, M., Gazzo, S., Wahbi, K., Callanan, M. B., Felman, P., Dumontet, C., Magaud, J., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1220 · Cited by 56 · see citing works

Coordinated regulation of differentiation and proliferation of embryonic cardiomyocytes by a jumonji (Jarid2)-cyclin D1 pathway

Nakajima, K., Inagawa, M., Uchida, C., Okada, K., Tane, S., Kojima, M., Kubota, M., Noda, M., Ogawa, S., Shirato, H., et al. (2011) · Development · doi:10.1242/dev.059295 · Cited by 54 · see citing works

MLL fusion-driven activation ofCDK6potentiates proliferation inMLL-rearranged infant ALL

der Linden, M. V., Willekes, M., Roon, E. H. J. V., Seslija, L., Schneider, P., Pieters, R., & Stam, R. W. (2014) · Cell Cycle · doi:10.4161/cc.27757 · Cited by 51 · see citing works

Therapeutic Targets in the ARF Tumor Suppressor Pathway

Saporita, A. J., Maggi, L. B., Apicelli, A. J., & Weber, J. D. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781058869 · Cited by 49 · see citing works

The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor

Ecker, A. (2009) · Frontiers in bioscience · doi:10.2741/3425 · Cited by 48 · see citing works

Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.

Brito‐Babapulle, V., Gruszka, A., Platt, G., Andersen, C. L., Elnenaei, M. O., Matutes, E., Wotherspoon, A. C., Weston-Smith, S., & Catovsky, D. (2002) · PubMed · Cited by 47 · see citing works

Transcriptional Regulation by a DNA-associated Form of Cyclin D1

Bienvenu, F., Barré, B., Giraud, S., Avril, S., & Coqueret, O. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-08-0654 · Cited by 47 · see citing works

Regulation of synthesis and activity of the PLSTIRE protein (cyclin-dependent kinase 6 (cdk6)), a major cyclin D-associated cdk4 homologue in normal human T lymphocytes.

Lucas, J. J., Szepesi, Á., Modiano, J. F., Domenico, J. M., & Gelfand, E. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.12.6275 · Cited by 47 · see citing works

Genetic Characterization of the Role of the Cip/Kip Family of Proteins as Cyclin-Dependent Kinase Inhibitors and Assembly Factors

Cerqueira, A., Martín, A. L., Symonds, C. E., Odajima, J., Dubus, P. R., Barbacid, M., & Santamarı́a, D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01163-13 · Cited by 47 · see citing works

Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis

Casimiro, M. C., Sante, G. D., Crosariol, M., Loro, E., Dampier, W., Ertel, A., Yu, Z., Saria, E. A., Παπανικολάου, Α., Li, Z., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3267 · Cited by 46 · see citing works

Multiple Mechanisms for E2F Binding Inhibition by Phosphorylation of the Retinoblastoma Protein C-Terminal Domain

Burke, J. R., Liban, T. J., Restrepo, T., Lee, H., & Rubin, S. M. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.09.031 · Cited by 45 · see citing works

Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 – 2014)

Malínková, V., Vylíčil, J., & Kryštof, V. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1045414 · Cited by 44 · see citing works

RB Restricts DNA Damage-Initiated Tumorigenesis through an LXCXE-Dependent Mechanism of Transcriptional Control

Bourgo, R. J., Thangavel, C., Ertel, A., Bergseid, J., McClendon, A. K., Wilkens, L., Witkiewicz, A. K., Wang, J. Y. J., & Knudsen, E. S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.029 · Cited by 42 · see citing works

Conserved RB functions in development and tumor suppression

Gordon, G. M., & Du, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1117-z · Cited by 42 · see citing works

Cyclin D3-dependent control of the dNTP pool and HIV-1 replication in human macrophages

Ruiz, A., Pauls, E., Badía, R., Torres‐Torronteras, J., Riveira‐Muñoz, E., Clotet, B., Martí, R., Ballana, E., & Esté, J. A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1030558 · Cited by 38 · see citing works

Expression of Cyclin-Dependent Kinase 6 (cdk6) and Frequent Loss of CD44 in Nasal-Nasopharyngeal NK/T-Cell Lymphomas: Comparison with CD56-Negative Peripheral T-Cell Lymphomas

Lien, H., Lin, C.-W., Huang, P., Chang, M., & Hsu, S.-M. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780093 · Cited by 34 · see citing works

Cyclin D3-associated Kinase Activity Is Regulated by p27kip1in BALB/c 3T3 Cells

Dong, F., Agrawal, D., Bagui, T. K., & Pledger, W. J. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.8.2081 · Cited by 34 · see citing works

Cyclin D1 Induces Chromosomal Instability

Casimiro, M. C., & Pestell, R. G. (2012) · Oncotarget · doi:10.18632/oncotarget.476 · Cited by 33 · see citing works

Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis

Rodríguez, E., Quereda, V., Bellutti, F., Prchal‐Murphy, M., Partida, D., Eguren, M., Kollmann, K., de Cedrón, M. G., Dubus, P. R., Cañamero, M., et al. (2014) · Blood · doi:10.1182/blood-2014-02-555292 · Cited by 33 · see citing works

CDK-Mediated Regulation of Cell Functions via c-Jun Phosphorylation and AP-1 Activation

Bush, T. J. V., & Bishop, G. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019468 · Cited by 32 · see citing works

CDK6 and p16INK4A in lymphoid malignancies

Kollmann, K., & Sexl, V. (2013) · Oncotarget · doi:10.18632/oncotarget.1541 · Cited by 32 · see citing works

PU.1 Directly Regulates cdk6 Gene Expression, Linking the Cell Proliferation and Differentiation Programs in Erythroid Cells*

Choe, K., Ujhelly, O., Wontakal, S. N., & Skoultchi, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077727 · Cited by 31 · see citing works

Clinicopathologic Features of CDK6 Translocation-associated B-cell Lymphoproliferative Disorders

Chen, D., Law, M. E., Theis, J. D., Gamez, J. D., Caron, L. B., Vrana, J. A., & Doǧan, A. (2009) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181934244 · Cited by 27 · see citing works

Kinase independent oncogenic cyclin D1

Casimiro, M. C., Arnold, A., & Pestell, R. G. (2015) · Aging · doi:10.18632/aging.100773 · Cited by 19 · see citing works

Cyclin D1 is a NF-κB corepressor

Rubio, M. F., Fernandez, P., Alvarado, C. V., Panelo, L. C., Grecco, M. R., Coló, G. P., Martínez-Noël, G. M. A., Micenmacher, S., & Costas, M. A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.009 · Cited by 17 · see citing works

CDK6 binds and promotes the degradation of the EYA2 protein

Kohrt, D., Crary, J. I., Zimmer, M., Patrick, A. N., Ford, H. L., Hinds, P. W., & Grossel, M. J. (2013) · Cell Cycle · doi:10.4161/cc.26755 · Cited by 16 · see citing works

Cell Cycle Inhibitors Make Progress

Brower, V. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju221 · Cited by 12 · see citing works

CDK6, a new target in MLL-driven leukemia

Antony‐Debré, I., & Steidl, U. G. (2014) · Blood · doi:10.1182/blood-2014-05-572917 · Cited by 10 · see citing works

Unexpected Outcomes of CDK4/6 Inhibition

Choi, Y. J., & Siciński, P. (2013) · Oncotarget · doi:10.18632/oncotarget.912 · Cited by 7 · see citing works

CDK6 is a regulator of stem cells “Egr” to wake up

Guzmán, M. L. (2015) · Blood · doi:10.1182/blood-2014-11-609230 · Cited by 7 · see citing works

Emerging Roles of Cell Cycle Regulators in Adipocyte Metabolism

Carine Chavey, A., Lagarrigue, S., Annicotte, J., & Lluis Fajas, A. (2012) · Springer eBooks · doi:10.1007/978-2-8178-0343-2_2 · Cited by 6 · see citing works

Medulloblastoma

Northcott, P. A., Robinson, G. W., Kratz, C. P., Mabbott, D., Pomeroy, S. L., Clifford, S. C., Rutkowski, S., Ellison, D. W., Malkin, D. M., Taylor, M. D., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0063-6 · Cited by 673 · see citing works

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

Yang, C., Li, Z., Bhatt, T., Dickler, M. N., Giri, D. D., Scaltriti, M., Baselga, J. M., Rosen, N. X., & Chandarlapaty, S. (2016) · Oncogene · doi:10.1038/onc.2016.379 · Cited by 413 · see citing works

Mechanisms of Sensitivity and Resistance to CDK4/6 Inhibition

Álvarez‐Fernández, M., & Malumbres, M. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.010 · Cited by 395 · see citing works

Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review

Pandey, K., An, H. J., Kim, S., Lee, S. A., Kim, S., Lim, S. M., Kim, G. M., Sohn, J., & Moon, Y. W. (2018) · International Journal of Cancer · doi:10.1002/ijc.32020 · Cited by 366 · see citing works

Cell-Cycle Proteins Control Production of Neutrophil Extracellular Traps

Amulic, B., Knackstedt, S. L., Abed, U. A., Deigendesch, N., Harbort, C. J., Caffrey, B. E., Brinkmann, V., Heppner, F. L., Hinds, P. W., & Zychlinsky, A. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.10.013 · Cited by 269 · see citing works

Structural insights into the functional diversity of the CDK–cyclin family

Wood, D. J., & Endicott, J. (2018) · Open Biology · doi:10.1098/rsob.180112 · Cited by 264 · see citing works

Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML

Brand, M., Jiang, B., Bauer, S., Donovan, K. A., Liang, Y., Wang, E. S., Nowak, R. P., Yuan, J. C., Zhang, T., Kwiatkowski, N., et al. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.11.006 · Cited by 258 · see citing works

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019)

Sánchez-Martínez, C., Lallena, M. J., Sanfeliciano, S. G., & de Dios, A. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126637 · Cited by 200 · see citing works

The role of CDK6 in cancer

Nebenfuehr, S., Kollmann, K., & Sexl, V. (2020) · International Journal of Cancer · doi:10.1002/ijc.33054 · Cited by 185 · see citing works

Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

Rugo, H. S., Huober, J., García-Sáenz, J. Á., Masuda, N., Sohn, J., Andre, V. A. M., Barriga, S., Cox, J., & Goetz, M. P. (2020) · The Oncologist · doi:10.1002/onco.13531 · Cited by 185 · see citing works

New and Emerging Targeted Therapies for Advanced Breast Cancer

Lau, K., Tan, A. M., & Shi, Y. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042288 · Cited by 171 · see citing works

Targeted protein degradation: current and future challenges

Hanzl, A., & Winter, G. E. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.012 · Cited by 157 · see citing works

Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders

Steinebach, C., Ng, Y. L. D., Sosič, I., Lee, C.-S., Chen, S., Lindner, S., Vu, L. P., Bricelj, A., Haschemi, R., Monschke, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc00167h · Cited by 148 · see citing works

CDK4/6 inhibitor resistance mechanisms and treatment strategies (Review)

Huang, J., Zheng, L., Sun, Z., & Li, J. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5184 · Cited by 141 · see citing works

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies

He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology &amp; Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126 · see citing works

Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib

Poratti, M., & Marzaro, G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.064 · Cited by 115 · see citing works

Aging effects on intestinal homeostasis associated with expansion and dysfunction of intestinal epithelial stem cells

Moorefield, E., Andres, S. F., Blue, R. E., Landeghem, L. V., Mah, A. T., Santoro, M. A., & Ding, S. (2017) · Aging · doi:10.18632/aging.101279 · Cited by 110 · see citing works

Cyclin-Dependent Kinases 4/6 Inhibitors in Breast Cancer: Current Status, Resistance, and Combination Strategies

Niu, Y., Xu, J., & Sun, T. (2019) · Journal of Cancer · doi:10.7150/jca.32628 · Cited by 98 · see citing works

Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional controlPreprint

Casà, V., Gines, M. M., Gusmao, E. G., Slotman, J. A., Zirkel, A., Josipović, N., Oole, E., van IJcken, W. F. J., Houtsmuller, A. B., Papantonis, A., et al. (2020) · Genome Research · doi:10.1101/gr.253211.119 · Cited by 91 · see citing works

Cdk2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage

Bačević, K., Lossaint, G., Achour, T. N., Georget, V., Fisher, D., & Dulić, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-12868-5 · Cited by 84 · see citing works

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation

Dall’Acqua, A., Sonego, M., Pellizzari, I., Pellarin, I., Canzonieri, V., D’Andrea, S., Benevol, S., Sorio, R., Giorda, G., Califano, D., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607012 · Cited by 79 · see citing works

Identification of Potentially Functional CircRNA-miRNA-mRNA Regulatory Network in Gastric Carcinoma using Bioinformatics Analysis

Yang, G., Zhang, Y., & Yang, J. (2019) · Medical Science Monitor · doi:10.12659/msm.916902 · Cited by 77 · see citing works

CDK6 Antagonizes p53-Induced Responses during Tumorigenesis

Bellutti, F., Tigan, A.-S., Nebenfuehr, S., Dolezal, M., Zojer, M., Grausenburger, R., Hartenberger, S., Kollmann, S., Doma, E., Prchal‐Murphy, M., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0912 · Cited by 76 · see citing works

Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts

Xie, Z., Hou, S., Yang, X., Duan, Y., Han, J., Wang, Q., & Liao, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02190 · Cited by 73 · see citing works

CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells

Zhang, L., Li, Y., Hu, C., Chen, Y., Chen, Z., Chen, Z., Zhang, J., & Fang, S. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01524-w · Cited by 68 · see citing works

Juvenile hormone promotes locust fat body cell polyploidization and vitellogenesis by activating the transcription of Cdk6 and E2f1

Wu, Z., Guo, W., Yang, L., He, Q., & Zhou, S. (2018) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2018.09.002 · Cited by 68 · see citing works

MSCs‑derived exosomes attenuate ischemia-reperfusion brain injury and inhibit microglia apoptosis might via exosomal miR-26a-5p mediated suppression of CDK6

Cheng, C., Chen, X., Wang, Y., Cheng, W., Zuo, X., Tang, W., & Huang, W. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00324-0 · Cited by 69 · see citing works

miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6

Zhu, H., Wang, G., Zhou, X., Song, X., Gao, H., Ma, C., Chang, H., Li, H., Liu, F., Lu, J., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.07.037 · Cited by 66 · see citing works

CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle

Fan, Y., Li, H., Liang, X., & Xiang, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.15253 · Cited by 62 · see citing works

Exosomal miR-21-5p contributes to ovarian cancer progression by regulating CDK6

Cao, J., Zhang, Y., Mu, J., Yang, D., Gu, X., & Zhang, J. (2021) · Human Cell · doi:10.1007/s13577-021-00522-2 · Cited by 61 · see citing works

Regulatory Mechanisms of Cell Polyploidy in Insects

Ren, D., Song, J., Ni, M., Kang, L., & Guo, W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00361 · Cited by 59 · see citing works

The interplay of CDK4 and CDK6 in melanoma

Kollmann, K., Briand, C., Bellutti, F., Schicher, N., Blunder, S., Zojer, M., & Höeller, C. (2019) · Oncotarget · doi:10.18632/oncotarget.26515 · Cited by 55 · see citing works

Palbociclib resistance confers dependence on an FGFR-MAP kinase-mTOR-driven pathway inKRAS-mutant non-small cell lung cancer

Haines, E., Chen, T., Kommajosyula, N., Chen, Z., Herter-Sprie, G. S., Cornell, L., Wong, K., & Shapiro, G. I. (2018) · Oncotarget · doi:10.18632/oncotarget.25803 · Cited by 53 · see citing works

A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification

Zhang, J., Liu, X., Zhou, W., Cheng, G., Wu, J., Guo, S., Jia, S., Liu, Y., Li, B., Zhang, X., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68224-7 · Cited by 50 · see citing works

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment

Scheiblecker, L., Kollmann, K., & Sexl, V. (2020) · Pharmaceuticals · doi:10.3390/ph13120418 · Cited by 47 · see citing works

STAT3-Induced lncRNA SNHG17 Exerts Oncogenic Effects on Ovarian Cancer through Regulating CDK6

Pan, X., Guo, Z., Chen, Y., Zheng, S., Peng, M., Yang, Y., & Wang, Z. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.006 · Cited by 47 · see citing works

Targeting CDK4/6 for Anticancer Therapy

Qi, J., & Ouyang, Z. (2022) · Biomedicines · doi:10.3390/biomedicines10030685 · Cited by 47 · see citing works

Identification of Targetable Lesions in Anaplastic Thyroid Cancer by Genome Profiling

Ravi, N., Yang, M., Gretarsson, S., Jansson, C., Mylona, N., Sydow, S., Woodward, E. L., Ekblad, L., Wennerberg, J., & Paulsson, K. M. (2019) · Cancers · doi:10.3390/cancers11030402 · Cited by 46 · see citing works

The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer

Zhou, W., Wang, W., Liang, Y., Jiang, R., Qiu, F.-S., Shao, X., Liu, Y., Fang, L., Ni, M., Yu, C.-H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39854-y · Cited by 45 · see citing works

CDK4 inhibition diminishes p53 activation by MDM2 antagonists

Sriraman, A., Dickmanns, A., Najafova, Z., Johnsen, S. A., & Dobbelstein, M. (2018) · Cell Death &amp; Disease · doi:10.1038/s41419-018-0968-0 · Cited by 40 · see citing works

Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis

Zangouei, A. S., Zangoue, M., Taghehchian, N., Zangooie, A., Rahimi, H. R., Saburi, E., Alavi, M. S., & Moghbeli, M. (2023) · Biological Research · doi:10.1186/s40659-022-00411-4 · Cited by 39 · see citing works

A comprehensive review on Ellagic acid in breast cancer treatment: From cellular effects to molecular mechanisms of action

Golmohammadi, M., Zamanian, M., Jalal, S., Noraldeen, S. A. M., Ramírez-Coronel, A., Oudaha, K. H., Obaid, R., Almulla, A. F., Bazmandegan, G., & Kamiab, Z. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3699 · Cited by 30 · see citing works

Reduction of Movement in Neurological Diseases: Effects on Neural Stem Cells Characteristics

Adami, R., Pagano, J., Colombo, M., Platonova, N., Recchia, D., Chiaramonte, R., Bottinelli, R., Canepari, M., & Bottai, D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00336 · Cited by 36 · see citing works

miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway

Shang, A., Lu, W., Yang, M. G., Zhou, C., Zhang, H., Cai, Z., Wang, W., Wang, W., & Wu, G. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1391825 · Cited by 36 · see citing works

CDK inhibitors reduce cell proliferation and reverse hypoxia-induced metastasis of neuroblastoma tumours in a chick embryo model

Swadi, R., Sampat, K., Herrmann, A., Losty, P. D., Sée, V., & Moss, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-45571-8 · Cited by 34 · see citing works

Cyclin-dependent kinases and rare developmental disorders

Colas, P. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01472-y · Cited by 31 · see citing works

JQ1, a selective inhibitor of BRD4, suppresses retinoblastoma cell growth by inducing cell cycle arrest and apoptosis

Zhang, Y., Duan, S., Jang, A., Mao, L., Liu, X., & Huang, G. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108304 · Cited by 28 · see citing works

SUMOylated MAFB promotes colorectal cancer tumorigenesis

Yang, L., Zhang, X., Xie, Y., Sun, X., Zhao, R., & Huang, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.13129 · Cited by 28 · see citing works

High GSTP1 inhibits cell proliferation by reducing Akt phosphorylation and is associated with a better prognosis in hepatocellular carcinoma

Liu, X., Tan, N., Liao, H., Pan, G., Xu, Q. R., Zhu, R., Zou, L., He, S., & Zhu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.23420 · Cited by 28 · see citing works

High-content analysis screening for cell cycle regulators using arrayed synthetic crRNA libraries

Strezoska, Ž., Perkett, M. R., Chou, E. T., Maksimova, E. M., Anderson, E. M., McClelland, S., Kelley, M. L., Vermeulen, A., & Smith, A. V. B. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.017 · Cited by 24 · see citing works

Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142

Zhang, L., Zhao, G., Ji, S., Yuan, Q., & Zhou, H. (2020) · Medical Science Monitor · doi:10.12659/msm.921594 · Cited by 27 · see citing works

Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016)

Giovanni, C. D., Novellino, E., Chilin, A., Lavecchia, A., & Marzaro, G. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1234603 · Cited by 25 · see citing works

Transcriptomic responses to silver nanoparticles in the freshwater unicellular eukaryote Tetrahymena thermophila

Piersanti, A., Juganson, K., Mozzicafreddo, M., Wei, W., Zhang, J., Zhao, K., Ballarini, P., Mortimer, M., Pucciarelli, S., Miao, W., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115965 · Cited by 24 · see citing works

Hsa_circ_0002062 Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells by Regulating the Hsa-miR-942-5p/CDK6 Signaling Pathway

Wang, Y., Tan, X., Wu, Y., Cao, S., Lou, Y., Zhang, L., & Hu, F. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673229 · Cited by 24 · see citing works

lncRNA SNHG15 Promotes Ovarian Cancer Progression through Regulated CDK6 via Sponging miR‐370‐3p

Wang, Y., Ding, M., Yuan, X., Ruibao, J., Zhu, D., Huang, W., Deng, W., & Liu, Y. (2021) · BioMed Research International · doi:10.1155/2021/9394563 · Cited by 24 · see citing works

AC002454.1 and CDK6 synergistically promote endometrial cell migration and invasion in endometriosis

Liu, J., Wang, Y., Chen, P., Ma, Y., Wang, S., Tian, Y., Wang, A., & Wang, D. (2019) · Reproduction · doi:10.1530/rep-19-0005 · Cited by 24 · see citing works

Extended proliferation of chicken‐ and Okinawa rail‐derived fibroblasts by expression of cell cycle regulators

Katayama, M., Kiyono, T., Ohmaki, H., Eitsuka, T., Endoh, D., Inoue‐Murayama, M., Nakajima, N., Onuma, M., & Fukuda, T. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27417 · Cited by 23 · see citing works

Histone deacetylases facilitate Th17-cell differentiation and pathogenicity in autoimmune uveitis via CDK6/ID2 axis

Zhang, C., Liu, X., Gu, C., Su, Y., Lv, J., Liu, Y., Gao, Y., Chen, H., Xu, N., Xiao, J., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.07.029 · Cited by 22 · see citing works

Pathways Controlling Formation and Maintenance of the Osteocyte Dendrite Network

Wang, J. S., & Wein, M. N. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00753-8 · Cited by 24 · see citing works

Disproportionality Analysis of Abemaciclib in the FDA Adverse Event Reporting System: A Real-World Post-Marketing Pharmacovigilance Assessment

Shu, Y., Wang, L., Ding, Y., & Zhang, Q. (2023) · Drug Safety · doi:10.1007/s40264-023-01334-z · Cited by 23 · see citing works

DDX20 is required for cell-cycle reentry of prospermatogonia and establishment of spermatogonial stem cell pool during testicular development in mice

Zou, D., Li, K., Su, L., Liu, J., Lu, Y., Huang, R., Li, M., Mang, X., Geng, Q., Li, P., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.04.002 · Cited by 22 · see citing works

Transcriptomic analysis reveals differential gene expression, alternative splicing, and novel exons during mouse trophoblast stem cell differentiation

Ullah, R., Naz, A., Akram, H. S., Ullah, Z., Tariq, M. S., Mithani, A., & Faisal, A. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01848-8 · Cited by 22 · see citing works

CDK6 Is a Therapeutic Target in Myelofibrosis

Dutta, A., Nath, D., Yang, Y., Le, B. T., & Mohi, G. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0590 · Cited by 21 · see citing works

Alleviation of DSS-induced colitis via bovine colostrum-derived extracellular vesicles with microRNA let-7a-5p is mediated by regulating Akkermansia and β -hydroxybutyrate in gut environments

Mun, D., Kang, M., Shin, M., Choi, H., Kang, A., Ryu, S., Unno, T., Maburutse, B. E., Oh, S., & Kim, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00121-23 · Cited by 21 · see citing works

A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?

Lang, P. Y., & Gershon, T. R. (2018) · BioEssays · doi:10.1002/bies.201700243 · Cited by 20 · see citing works

Circular RNA circ_ASAP2 promotes cell viability, migration, and invasion of gastric cancer cells by regulating the miR-770-5p/CDK6 axis.

Chen, B., Ji, F., Wen, X., & Jin, Z. (2020) · PubMed Central · Cited by 20 · see citing works

LncRNA ROR modulates myocardial ischemia-reperfusion injury mediated by the miR-185-5p/CDK6 axis

Sun, J., Zhu, Y., Liu, Q., Hu, Y.-H., Li, C., Jie, H., Xu, G., Xiao, R., Xing, X., Yu, S., et al. (2022) · Laboratory Investigation · doi:10.1038/s41374-021-00722-2 · Cited by 20 · see citing works

Combined Luteolin and Indole-3-Carbinol Synergistically Constrains ERα-Positive Breast Cancer by Dual Inhibiting Estrogen Receptor Alpha and Cyclin-Dependent Kinase 4/6 Pathway in Cultured Cells and Xenograft Mice

Wang, X., Zhang, L., Dai, Q., Si, H., Zhang, L., Eltom, S. E., & Si, H. (2021) · Cancers · doi:10.3390/cancers13092116 · Cited by 20 · see citing works

Progress in understanding the relationship between long noncoding RNA and endometriosis

Yan, W., Hu, H., & Tang, B. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2019.100067 · Cited by 20 · see citing works

Insights into phosphorylation-induced influences on conformations and inhibitor binding of CDK6 through GaMD trajectory-based deep learning

Zhao, L., Wang, J., Yang, W., Zhang, C., Zhang, W., & Chen, J. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d4cp04579c · Cited by 19 · see citing works

Simulated Microgravity Inhibits the Proliferation of Chang Liver Cells by Attenuation of the Major Cell Cycle Regulators and Cytoskeletal Proteins

Ho, C. N. Q., Tran, M. T., Chung, Đ. C., Sơn, H. N., Tran, D. H., & Long, L. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094550 · Cited by 19 · see citing works

Role of NF-kappaB2-p100 in regulatory T cell homeostasis and activation

Dhar, A., Chawla, M., Chattopadhyay, S., Oswal, N., Umar, D., Gupta, S., Bal, V., Rath, S., George, A., Arimbasseri, G. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50454-z · Cited by 19 · see citing works

Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them

Foffano, L., Cucciniello, L., Nicolò, E., Migliaccio, I., Noto, C., Reduzzi, C., Malorni, L., Cristofanilli, M., Gerratana, L., & Puglisi, F. (2024) · The Breast · doi:10.1016/j.breast.2024.103863 · Cited by 18 · see citing works

T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo

Klein, K., Witalisz‐Siepracka, A., Gotthardt, D., Agerer, B., Sternberg, F., Grausenburger, R., Knab, V. M., Bergthaler, A., & Sexl, V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650977 · Cited by 18 · see citing works

C-phycocyanin decreases proliferation and migration of melanoma cells: In silico and in vitro evidences

Salgado, M. T. S. F., Silva, E. F. E., Matsumoto, A. M., Mattozo, F. H., de Amarante, M. C. A., Kalil, S. J., & Votto, A. P. D. S. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105757 · Cited by 18 · see citing works

Cyclin-dependent kinase 6 (CDK6) as a potent regulator of the ovarian primordial-to-primary follicle transition

Ataei-Nazari, S., Amoushahi, M., Madsen, J., Jensen, J., Heuck, A., Mohammadi‐Sangcheshmeh, A., & Lykke‐Hartmann, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1036917 · Cited by 18 · see citing works

Strategy of combining CDK4/6 inhibitors with other therapies and mechanisms of resistance

Xue, Y. (2024) · International Journal of Clinical and Experimental Pathology · doi:10.62347/hgni4903 · Cited by 18 · see citing works

The CDK6-c-Jun-Sp1-MMP-2 axis as a biomarker and therapeutic target for triple-negative breast cancer.

Luo, C., Hou, M., Huang, C., Wu, C., Ou‐Yang, F., Li, Q.-L., Wu, C.-C., & Pan, M. (2020) · PubMed Central · Cited by 18 · see citing works

Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration

Chen, Q., Fu, L., Hu, J., Guo, G., & Xie, A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01934-8 · Cited by 17 · see citing works

CASC21, a FOXP1 induced long non-coding RNA, promotes colorectal cancer growth by regulating CDK6

Gong, T., Yu, L., Feng, L., Fang, M., Dai, G., Huang, X. Y., Yang, Y., & Liu, S. (2020) · Aging · doi:10.18632/aging.103376 · Cited by 17 · see citing works

miR‑449a‑5p suppresses CDK6 expression to inhibit cardiomyocyte proliferation

Li, B., Zhi, W., Yang, F., Huang, J., Hu, X., Deng, S., Tian, M., & Si, X. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11652 · Cited by 17 · see citing works

High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis

Zhu, D., Gu, X., Lin, Z., Yu, D., & Wang, J. (2021) · Oncogenesis · doi:10.1038/s41389-021-00330-1 · Cited by 16 · see citing works

C4orf19 inhibits colorectal cancer cell proliferation by competitively binding to Keap1 with TRIM25 via the USP17/Elk-1/CDK6 axis

Huang, S., Li, J., Wu, S., Zheng, Z., Wang, C., Li, H., Zhao, L., Zhang, X., Huang, H., Huang, C., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02656-z · Cited by 16 · see citing works

Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts

Soamalala, J., Diot, S., Pellerano, M., Blanquart, C., Galibert, M., Jullian, M., Puget, K., & Morris, M. C. (2020) · ChemBioChem · doi:10.1002/cbic.202000677 · Cited by 16 · see citing works

Identification of Functional lncRNAs Associated With Ovarian Endometriosis Based on a ceRNA Network

Bai, J., Wang, B., Wang, T., & Ren, W. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.534054 · Cited by 16 · see citing works

CDK6 is upregulated and may be a potential therapeutic target in enzalutamide-resistant castration-resistant prostate cancer

Chen, X., Wu, Y., Wang, X., Xu, C., Wang, L., Jian, J., Wu, D., & Wu, G. (2022) · European journal of medical research · doi:10.1186/s40001-022-00730-y · Cited by 16 · see citing works

PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives

Vicente, A. T. S., & Salvador, J. A. R. (2024) · MedComm · doi:10.1002/mco2.575 · Cited by 14 · see citing works

Knockdown of ALPK2 blocks development and progression of renal cell carcinoma

Jiang, J., Han, P., Qian, J., Zhang, S., Wang, S., Cao, Q., & Shao, P. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112029 · Cited by 14 · see citing works

CDC42EP3 promotes colorectal cancer through regulating cell proliferation, cell apoptosis and cell migration

Feng, Q., Xu, D., Zhou, M., Wu, Z., Wu, Z., Wang, Z., Bi, J., & Pei, W. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01845-8 · Cited by 14 · see citing works

Identification of Upstream Kinases by Fluorescence Complementation Mass Spectrometry

Zeng, L., Wang, W., Arrington, J. V., Shao, G., Geahlen, R. L., Hu, C., & Tao, W. A. (2017) · ACS Central Science · doi:10.1021/acscentsci.7b00261 · Cited by 13 · see citing works

Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of oral cancer

Doghish, A. S., Elshaer, S. S., Fathi, D., Rizk, N. I., Elrebehy, M. A., AL‐Noshokaty, T. M., Elballal, M. S., Abdelmaksoud, N. M., Abdel‐Reheim, M. A., Mageed, S. S. A., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155027 · Cited by 13 · see citing works

microRNA-524-5p inhibits proliferation and induces cell cycle arrest of osteosarcoma cells via targeting CDK6

Chen, H., Cheng, C., & Gao, S. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.092 · Cited by 13 · see citing works

Simulated Microgravity Reduces Proliferation and Reorganizes the Cytoskeleton of Human Umbilical Cord Mesenchymal Stem Cells

Chi, H., SON, H., Chung, Đ. C., HUAN, L., DIEM, T., & Long, L. T. (2020) · Physiological Research · doi:10.33549/physiolres.934472 · Cited by 13 · see citing works

Cyclin-dependent kinase 6 (CDK6) is a candidate diagnostic biomarker for early non-small cell lung cancer

Gong, W., Wang, L., Zheng, Z., Chen, W., Du, P., & Zhao, H. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.11.21 · Cited by 12 · see citing works

Investigating the Mechanism of Inhibition of Cyclin-Dependent Kinase 6 Inhibitory Potential by Selonsertib: Newer Insights Into Drug Repurposing

Baig, M. H., Yousuf, M., Khan, M. I., Khan, I., Ahmad, I. S., Alshahrani, M. Y., Hassan, M. I., & Dong, J.-J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.865454 · Cited by 12 · see citing works

Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning

Zhao, L., Wang, J., Yang, W., Zhao, K., Sun, Q., & Chen, J. (2024) · Molecules · doi:10.3390/molecules29112681 · Cited by 11 · see citing works

Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcription controlPreprint

Casà, V., Gines, M. M., Gusmao, E. G., Slotman, J. A., Zirkel, A., Josipović, N., Oole, E., van IJcken, W. F. J., Houtsmuller, A. B., Papantonis, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/642959 · Cited by 11 · see citing works

Protein Phosphorylation Alterations in Myotonic Dystrophy Type 1: A Systematic Review

Costa, A., Cruz, A. C., Martins, F., & Rebelo, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043091 · Cited by 10 · see citing works

CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway

Cheng, C., Yang, S.-C., Lai, C.-Y., Wang, C.-K., Chang, C., Lin, C.-Y., Chen, W., Lin, P.-Y., Wu, H., Ma, N. J.-L., et al. (2020) · Cells · doi:10.3390/cells9071706 · Cited by 10 · see citing works

CDK6 Antagonizes TP53-Induced Responses during Tumorigenesis

Sexl, V., Kollmann, K., & Bellutti, F. (2019) · Blood · doi:10.1182/blood-2019-121101 · Cited by 1 · see citing works

The role of CDK6 in cancer

Nebenfuehr, S., Kollmann, K., & Sexl, V. (2020) · International Journal of Cancer · doi:10.1002/ijc.33054 · Cited by 185 · see citing works

The Kinase-Independent, Second Life of CDK6 in Transcription

Otto, T., & Siciński, P. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.07.019 · Cited by 25 · see citing works

P325: A KINASE-DEAD VARIANT OF CDK6 IS ASSOCIATED WITH REDUCED TUMORIGENIC POTENTIAL AND A DISTINCT TRANSCRIPTIONAL REWIRING IN AN ALL MODEL

Klampfl, T., Nebenfuehr, S., Zojer, M., Bellutti, F., Sexl, V., & Kollmann, K. (2022) · HemaSphere · doi:10.1097/01.hs9.0000844188.05453.f2

Targeting CDK6 in cancer: State of the art and new insights

Tadesse, S., Yu, M., Kumarasiri, M., Le, B. T., & Wang, S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1084445 · Cited by 166 · see citing works